Vital Breast Cancer Information


Breast Cancer Articles Home Page | Health57.com Home Page

The

Vital information and articles related to Breast Cancer


Lets Start Screening For Breast Health


In the United States, American women are told to begin annual mammographic screening for breast cancer at the age of 40. Long before we've reached this age, we are advised to perform a monthly breast exam and see our doctors for a clinical breast exam (CBE) annually as well. However, the detection rate of breast cancer for CBE is only 47% when the tumors are less than 1 centimeter while mammography has given us a 70% detection rate. By the time a tumor is detected by palpation or found mammographically, it has already been growing and developing for 8-10 years.

Mammography has a high false positive rate. Only 1:6 biopsies are found to be positive for cancer when performed due to a positive mammogram or CBE. This places additional stressors on women who undergo these procedures.

Other risks of mammography include the radiation that each breast is exposed to during a mammogram. During a chest X-ray, a person receives 1/1000 of a RAD, or radiation absorbed dose. This type of X-ray is a high energy X-ray. During a mammogram, however, the X-ray used is a low energy X-ray and results in 1 RAD or a 1000-fold greater exposure than a simple chest X-ray. It has been suggested that the low energy X-ray used may cause greater biological damage which is cumulative over time. In a journal entitled Radiation Research and published in 2004, the author concludes that the risks associated with mammography screening may be FIVE times higher than previously assumed and the risk-benefit relationship of mammography exposures need to be re-examined.

In 1982, the FDA approved thermography as an adjunctive tool for breast cancer screening. Digital Infrared Thermal Imaging, also known as DITI measures heat emitted from the body and is accurate to 1/100th of a degree. Certified Clinical Thermographers follow strict guidelines and transmit their scans for interpretation by board certified thermologists. DITI examines physiology, NOT structure. It is in this capacity that DITI can monitor breast HEALTH over time and alert a patient or physician to a developing problem; possibly before a lump can be seen on X-ray or palpated clinically. There are no test limitations such as breast density. Women with cosmetic implants are great candidates for thermography which emits no radiation and no compression. Contact is never made during a thermographic scan.

Clinical research studies continue to support thermography's role as an adjunctive tool in breast cancer screening and the ONLY tool that measures breast health. There are now more than 800 publications on over 300,000 women in clinical trials. A recent finding published in the American Journal of Radiology in 2003 showed that thermography has 99% sensitivity in identifying breast cancer with single examinations and limited views. Scientists concluded that a negative thermogram is powerful evidence that cancer is not present.

In conclusion, women need to begin breast health screening early; as young as age 25. This can provide women with the earliest possible indication that further investigation is necessary. It takes approximately 15 years for a breast cancer to form and lead to death. If "early detection is the best prevention," let's start using technology that truly allows for the earliest possible alert to a developing problem.

Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com.

Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She is an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area.


MORE RESOURCES:

Osteo Drug Stops Bone Loss From Breast Cancer Chemo
Washington Post, United States - 6 hours ago
The multicenter, phase III study is the first to evaluate the use of zoledronic acid in premenopausal breast cancer patients. The 101 women (85 completed ...


Sydney Morning Herald

When to Visit a High-Risk Breast Cancer Center
U.S. News & World Report, DC - 22 hours ago
When I blogged yesterday about Christina Applegate's revelation that she carried a breast cancer gene mutation, I didn't realize she was one of the lucky ...
Health: Breast Cancer CBS 3
Applegate and Breast Cancer Treatment abc40
Susan Reimer Baltimore Sun
InjuryBoard.com - South Carolina Now
all 1,105 news articles


Breast Cancer 3-Day event needs you
WKYC-TV, OH - 1 hour ago
CLEVELAND -- Nearly 1700 men and women will soon fill the streets for the 2008 Cleveland Breast Cancer 3-Day, a 60-mile, three-day journey that raises ...


Livial® Reduces Breast Cancer Risk but Increases Stroke Risk
Cancer Consultants, ID - 3 hours ago
Livial® (tibolone), an agent used to reduce menopausal symptoms as well as bone loss, significantly reduces the risk of breast cancer and prevents bone loss ...


Heather Jose: One Day Everything Is Normal And Then…Breast Cancer
EmpowHer, AZ - 1 hour ago
I had a mammogram and an ultrasound all the while being told that I was too young to have breast cancer. My day ended by lying on a table crying silent ...


Celebs unite for National Breast Cancer Foundation
Courier Mail, Australia - 6 hours ago
HAVING all been personally hit in some way by the heartache that comes with a breast cancer diagnosis, four female celebs have banded together for a TV ...


Bonners Ferry Pair Walking Down Breast Cancer
Ruralnorthwest.com, ID - 6 hours ago
In the last seven years, Mellett - who owns Bonners Ferry Funeral Home with her husband, Mick - has lost two aunts to breast cancer, as well as several ...


Currently Druggable in Breast Cancer: A Drug Target Competitive ...
Business Wire (press release), CA - 11 hours ago
This report aims to analyze the current and future potential of breast cancer pipeline by examining key fundamentals across the entire pipeline of drug ...


Zoledronate prevents bone loss during endocrine treatment for ...
Medicexchange, UK - 11 hours ago
... adjuvant endocrine therapy for early-stage breast cancer in premenopausal women, investigators report in the September issue of The Lancet Oncology. ...
Osteoporosis drug for breast cancer Montrose Today
all 4 news articles


Comparison of Prognostic Gene Expression signatures for Breast Cancer
7thSpace Interactive (press release), NY - 12 hours ago
However, signatures were never compared on an independent population of untreated breast cancer patients, where risk assessment was computed using the ...

Breast-Cancer - Google News



Breast Cancer Articles Home Page | Breast Cancer Articles Site Map | Health News | Health
Hairstyles | Fashion57.com | Beauty

Holistic Health | Womens Health | Mens Health | Childrens Health | Pharmacy | Medical | Herbs | Vitamins | Exercise

Health57.com - all Vital information and articles related to Breast Cancer.

© 2006